Fig. 7

Silencing of RIN3 results in changes in cell proliferation and migration. (A) The relative expression of RIN3 in the RIN3-sh1, RIN3-sh2, and NC groups within the RIN3 knockdown MCF-7 cancer cell lines was evaluated. (B) The CCK-8 assay demonstrated that knockdown of RIN3 notably inhibited the proliferation of breast cancer cells. (C) Wound healing experiments were conducted on cancer cells in the RIN3-sh1, RIN3-sh2, and NC groups. (D) A comparative analysis of clone formation was carried out among the RIN3-sh1, RIN3-sh2, and control cell lines.